Treatment of anxiety and depressive disorders in patients with cardiovascular disease

AUTOR(ES)

Davies, Simon J C

FONTE

BMJ Publishing Group Ltd.

RESUMO

What role do selective serotonin reuptake inhibitors have in treating psychiatric morbidity in patients with cardiovascular disease? This review discusses the safety and efficacy of various antidepressants in this group of patients and their potential for improving cardiovascular outcomes

Documentos Relacionados

• Risk factors, prevalence, and treatment of anxiety and depressive disorders in Pakistan: systematic review
• Separation of anxiety and depressive disorders: Authors' reply
• Web-based exercise interventions for patients with depressive and anxiety disorders: a systematic review of randomized controlled trials
• The role of long-term psychodynamic psychotherapy in improving attachment patterns, defense styles, and alexithymia in patients with depressive/anxiety disorders
• Mental health resources and awareness of anxiety and depressive disorders in general hospitals in China